108 results
P
patients with age-related macular degeneration (AMD), controls
I/C
IL-8 gene polymorphisms, IL-8 level, allelic (T vs. C), dominant (TT + CT vs. CC), homozygous (TT vs. CC), heterozygous (CT vs. CC)
O
risk of age-related macular degeneration (AMD), elevated level of IL-8, wet AMD
P
adult patients with psoriasis and psoriatic arthritis
I/C
IL-17 and IL-23 inhibitors, placebo
O
serious infection, overall infection, malignancy, nasopharyngitis
P
COVID-19 patients
I/C
Targeting IL-17A, Disease severity
O
Serum IL-17A levels
P
292 individuals with major depressive disorder
I/C
fluoxetine treatment
O
decreased levels of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α)
P
OSA, control
I/C
effective treatments, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, IL-18, IL-23
O
pg/ml
P
surgical patients
I/C
peripheral levels of Insulin-like Growth Factor-1 (IGF-1), C-Reactive Protein (C-RP) and Interleukin-6 (IL-6), delirium in surgical patients
O
association between peripheral levels of IGF-1, C-RP and IL-6 and delirium
P
SRSF1, lymphocytes
I/C
conditional deletion, wild type
O
increased expression of IL-17A and IL-17F
P
patients with COVID-19
I/C
IL-6, severe disease and mortality
O
adequate predictor of severe disease
P
children and adolescents with febrile urinary tract infections (UTI), healthy children
I/C
serum and urinary levels of interleukins (IL), other febrile conditions in children and adolescents
O
diagnostic utility of ILs 8 and 6 urinary levels
P
moderate to severe atopic dermatitis (AD)
I/C
IL-13 inhibitors, placebo treatment
O
efficacy and safety